Table 1.
Clinical and demographic characteristics of patients and control subjects.
| Sex | Age | PD duration | Hohen and Yahr | UPDRS off-state | MMSE | LEDD (mg) | |
|---|---|---|---|---|---|---|---|
| PD PATIENTS | |||||||
| 1 | m | 59 | 3 | 1.5 | 14 | 28 | 450 |
| 2 | m | 75 | 3 | 2 | 19 | 27 | 450 |
| 3 | m | 58 | 2 | 1 | 19 | 30 | 450 |
| 4 | m | 64 | 3 | 2 | 19 | 27 | 450 |
| 5 | m | 64 | 5 | 2 | 14 | 28 | 500 |
| 6 | m | 65 | 5 | 2.5 | 25 | 26 | 500 |
| 7 | m | 67 | 4 | 2 | 24 | 26 | 500 |
| 8 | m | 69 | 5 | 3 | 30 | 26 | 500 |
| 9 | f | 60 | 5 | 2 | 18 | 27 | 500 |
| 10 | f | 65 | 2 | 1 | 8 | 28 | 400 |
| 11 | f | 69 | 5 | 3 | 30 | 25 | 800 |
| Mean | 65 | 3.8 | 2 | 20 | 27.1 | 500 | |
| CONTROLS | |||||||
| 1 | f | 60 | |||||
| 2 | m | 76 | |||||
| 3 | f | 56 | |||||
| 4 | m | 68 | |||||
| 5 | m | 63 | |||||
| 6 | m | 63 | |||||
| 7 | m | 66 | |||||
| 8 | m | 71 | |||||
| 9 | m | 59 | |||||
| 10 | m | 64 | |||||
| 11 | f | 70 | |||||
| Mean | 65.1 | ||||||
UPDRS, Unified Parkinson’s Disease Rating Scale; MMSE, Mini-Mental State Examination; LEDD: Levodopa equivalent daily dose.